MedPath
HSA Approval

SODIUM CHLORIDE 0.45% AND GLUCOSE 2.5% INTRAVENOUS INFUSION BP

SIN07991P

SODIUM CHLORIDE 0.45% AND GLUCOSE 2.5% INTRAVENOUS INFUSION BP

SODIUM CHLORIDE 0.45% AND GLUCOSE 2.5% INTRAVENOUS INFUSION BP

January 24, 1995

B. BRAUN SINGAPORE PTE LTD

B. BRAUN SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantB. BRAUN SINGAPORE PTE LTD
Licence HolderB. BRAUN SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS

Medical Information

B05BB02

electrolytes with carbohydrates

Manufacturer Information

B. Braun Singapore Pte Ltd.

B BRAUN MEDICAL INDUSTRIES SDN BHD

Active Ingredients

SODIUM CHLORIDE

0.45 g/100 ml

Sodium chloride

GLUCOSE MONOHYDRATE

2.75 g/100 ml

Glucose

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SODIUM CHLORIDE 0.45% AND GLUCOSE 2.5% INTRAVENOUS INFUSION BP - HSA Approval | MedPath